ArticleClinical rheumatology2025

Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.

Leslie R Harrold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.